CTIX isn't paying much for clinical trials. U of Bologna is paying for their trial, except for the Kevetrin that the company supplies, and some trials are covered by government grants (like that Fox Chase one). It's truly amazing how far CTIX has come with all these clinical trials, for VERY little money compared to most companies. This, from a company that was on the verge of bankruptcy when Leo Ehrlich took over as CEO, and had to lend the company 2 million bucks of his own money because he couldn't get financing. Now look -- 4 clinical trials, with the very likely possibility of the U of B one getting started soon.

So ridiculous when those dopes on other boards try to criticize this CEO. Amazing how many high school kids sitting in their parents' basements think that they know more about running this company than Leo does.